On June 16, Naru Intelligence will participate in the second Chapter of Health 2.0 Basque, to be held within the European Congress of Digital Health “Innovating to advance” in Donostia.
We will introduce our Step product, which is a system to personalize the care of breast cancer patients. Step analyzes data to identify patient profiles in which cancer treatments have been effective or not. Currently the context in which treatments fail is not saved nor analyzed, and precisely this is the value that Step provides. We integrate clinical information with patient reported follow-up information that is not gathered currently. Such new information is collected using the Step App, a mobile application for the patient.
Step has now been applied to breast cancer, but it can be also extended to other cancers and, in the future, to other chronic diseases.
More information: http://bit.ly/2qQ3oT5